Real-world outcomes of the TECNIS Eyhance IOL

Purpose: To evaluate visual and refractive outcomes obtained with an intraocular lens (IOL) in a large, unselected cohort at an Argentine cataract surgery center. Methods: This retrospective consecutive-case study included patients implanted with the TECNIS Eyhance IOL (ICB00) between November 2020 and November 2024. Postoperative evaluation was performed at one month. Recorded variables included preoperative corrected distance visual acuity (CDVA) and postoperative uncorrected distance visual acuity (UDVA) in logarithmic scale, uncorrected near visual acuity (UNVA) at 32 cm, manifest spherical equivalent (SE), implanted IOL power, and the presence of complications. Near visual acuity was measured with a Jaeger chart until March 2023 and subsequently with a standardized logarithmic chart (Byromat); Jaeger values were converted to logMAR for analysis. Results: A total of 899 eyes from 518 patients were included. The mean implanted IOL power was 22.1 ±2.5 D. Preoperative SE averaged 1.23 ±2.3 D, decreasing to -0.42 ±0.50 D postoperatively. Preoperative CDVA was 0.16 logMAR, improving to a postoperative UDVA of 0.04 logMAR. No eye lost lines of vision. UNVA demonstrated functional performance, with most measurements between J1 and J3 during the initial phase. Using the logarithmic chart, mean UNVA at 32 cm was 0.26 ±0.11 logMAR, with most eyes between 0.2–0.3 logMAR. Conclusion: The Eyhance IOL provided reliable uncorrected distance and functional near visual outcomes, with a favorable safety profile throughout the four-year study period.